NCT00648427View on ClinicalTrials.gov

Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

May 31, 2005

Conditions
Healthy
Interventions
DRUG

Paroxetine Hydrochloride Controlled-Release Tablets 25 mg

25mg, single dose fasting

DRUG

Paxil CR™ Tablets 25 mg

25mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648427 - Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg | Biotech Hunter | Biotech Hunter